IMPRiND Project

IMPRiND Symposium at AD/PD™ 2019

IMPRiND is organising a symposium during the 14th International Conference on Alzheimer's & Parkinsons's Diseases AD/PD™ 2019 entitled “The biochemical properties and cellular effects of proteopathic assemblies”. Saturday, March 30, 2019 from 17:15-19:15, Lisbon, Portugal. AD/PD™ 2019 program

Nature Medicine by IMPRiND partner Mathias Jucker

Detection and monitoring of pre-symptomatic Alzheimer's disease possible according to new study in Nature Medicine by IMPRiND partner Mathias Jucker Article

5th IMPRiND Consortium meeting in Lisbon on the 25th March

Looking forward to the 5th IMPRiND Consortium meeting in Lisbon on the 25th March. Lot's of exciting progress to be discussed.

IMPRiND publishable summary now available!

The first publishable summary of the IMPRiND project activities, summarising the first year of our activities, is now available on our Outcomes page, together with our growing list of publications. Enjoy reading!

Charlotte Delay from Janssen wins Best poster at the IMI 10th Anniversary Symposium

At the IMI 10th anniversary scientific symposium, held on 22-23 October 2018 in Brussels, 72 posters and 25 oral presentations were selected to showcase young scientists from IMI projects. Charlotte Delay from Janssen Pharmaceuticals, was awarded first prize for her poster: "Comparative assessment of seed extraction methods relevant for the study of Alzheimer disease". Abstract.

Show more posts

This project receives funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 116060. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

This work is supported by the Swiss State Secretariat for Education‚ Research and Innovation (SERI) under contract number 17.00038.

The opinions expressed and arguments employed herein do not necessarily reflect the official views of these funding bodies.